Full Press Release Details
autolusannualreport statement of liabilities parent company
AUTL
autolusannualreport statement of liabilities parent company
Key Takeaway: autolusannualreport statement of liabilities parent company
Price reaction · baseline $1.75 (2025-05-30 close) · clean, no other AUTL news in the window
day 0 close
+9.1%
day 1
+18.3%
day 3 · peak
+29.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
11.6%
average across 2 past catalysts
Cash runway
~24 mo
Low dilution risk
Lead asset
Obecabtagene autoleucel
Phase 2 · Lupus Nephritis